The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Complement System Part II: Role in Immunity
Open accessAbstract
The complement system has been considered for a long time as a simple lytic cascade, aimed to kill bacteria infecting the host organism. Nowadays, this vision has changed and it is well accepted that complement is a complex innate immune surveillance system, playing a key role in host homeostasis, inflammation, and in the defense against pathogens. This review discusses recent advances in the understanding of the role of complement in physiology and pathology. It starts with a description of complement contribution to the normal physiology (homeostasis) of a healthy organism, including the silent clearance of apoptotic cells and maintenance of cell survival. In pathology, complement can be a friend or a foe. It acts as a friend in the defense against pathogens, by inducing opsonization and a direct killing by C5b-9 membrane attack complex and by triggering inflammatory responses with the anaphylatoxins C3a and C5a. Opsonization plays also a major role in the mounting of an adaptive immune response, involving antigen presenting cells, T-, and B-lymphocytes. Nevertheless, it can be also an enemy, when pathogens hijack complement regulators to protect themselves from the immune system. Inadequate complement activation becomes a disease cause, as in atypical hemolytic uremic syndrome, C3 glomerulopathies, and systemic lupus erythematosus. Age-related macular degeneration and cancer will be described as examples showing that complement contributes to a large variety of conditions, far exceeding the classical examples of diseases associated with complement deficiencies. Finally, we discuss complement as a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–280 of 280
Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes
Sayah, S., Jauneau, A.-C., Patte‐Mensah, C., Tonon, M., Vaudry, H., & Fontaine, M. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00046-9 · Cited by 89
Baudino, L., Sardini, A., Ruseva, M. M., Fossati‐Jimack, L., Cook, H. T., Scott, D., Simpson, E., & Botto, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316877111 · Cited by 88
Soluble CR1 Therapy Improves Complement Regulation in C3 Glomerulopathy
Zhang, Y., Nester, C., Holanda, D. G., Marsh, H. C., Hammond, R. A., Thomas, L. J., Meyer, N. C., Hunsicker, L. G., Sethi, S. M., & Smith, R. J. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010045 · Cited by 86
Chemotaxis by mouse macrophage cell lines.
Aksamit, R. R., Falk, W., & Leonard, E. J. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.6.2194 · Cited by 85
The Making of a Macromolecular Machine: Assembly of the Membrane Attack Complex
Bubeck, D. (2014) · Biochemistry · doi:10.1021/bi500157z · Cited by 84
Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., & Loirat, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1308826 · Cited by 83
Autoantibodies against Complement C1q Specifically Target C1q Bound on Early Apoptotic Cells
Bigler, C., Schaller, M. M., Perahud, I., Osthoff, M. F., & Trendelenburg, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803573 · Cited by 82
Complement Factor I Promotes Progression of Cutaneous Squamous Cell Carcinoma
Riihilä, P., Nissinen, L. M., Farshchian, M., Kivisaari, A., Ala‐aho, R., Kallajoki, M. A., Grenman, R. A., Meri, S., Peltonen, S. A., Peltonen, J. T. K., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.376 · Cited by 81
Gorgani, N. N., He, J. Q., Katschke, K. J., Helmy, K. Y., Xi, H., Steffek, M., Hass, P. E., & Campagne, M. V. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7902 · Cited by 80
Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis
Yin, Y., Wu, X., Shan, G., & Zhang, X. (2012) · Lupus · doi:10.1177/0961203312451202 · Cited by 80
Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes
Degn, S. E., Kjær, T. R., Kidmose, R. T., Jensen, L., Hansen, A. G., Tekin, M., Jensenius, J. C., Andersen, G. R., & Thiel, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406849111 · Cited by 77
Arkwright, P. D., Riley, P., Hughes, S. M., Alachkar, H., & Wynn, R. F. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.035 · Cited by 76
Complement Factor H Autoantibodies Are Associated with Early Stage NSCLC
Amornsiripanitch, N., Hong, S.-L., Campa, M. J., Frank, M. M., Gottlin, E. B., & Patz, E. F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0321 · Cited by 76
Baruah, P., Dumitriu, I. E., Malik, T. H., Cook, H. T., Dyson, J., Scott, D., Simpson, E., & Botto, M. (2009) · Blood · doi:10.1182/blood-2008-06-164392 · Cited by 75
C4a: An Anaphylatoxin in Name Only
Barnum, S. R. (2015) · Journal of Innate Immunity · doi:10.1159/000371423 · Cited by 75
Roumenina, L. T., Sène, D., Radanova, M. A., Blouin, J., Halbwachs‐Mecarelli, L., Dragon‐Durey, M., Fridman, W. H., & Frémeaux‐Bacchi, V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101749 · Cited by 74
Self-citationHebecker, M., Alba‐Domínguez, M., Roumenina, L. T., Reuter, S., Hyvärinen, S., Dragon‐Durey, M., Jokiranta, T. S., Sánchez‐Corral, P., & Józsi, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300269 · Cited by 73
Self-citationKretzschmar, T., Jeromin, A., Gietz, C., Bautsch, W., Klos, A., Köhl, J., Rechkemmer, G., & Bitter-Suermann, D. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230239 · Cited by 71
Amarilyo, G., Verbovetski, I., Atallah, M., Grau, A., Wiser, G., Gill, O., Ben‐Neriah, Y., & Mevorach, D. (2009) · European Journal of Immunology · doi:10.1002/eji.200838951 · Cited by 71
Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b
Koch, T. K., Reuter, M., Barthel, D., Böhm, S., van den Elsen, J. M. H., Kraiczy, P., Zipfel, P. F., & Skerka, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047638 · Cited by 71
Histamine-Induced Inhibition of Normal Human Basophil Chemotaxis to C5a
Lett-Brown, M. A., & Leonard, E. J. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.118.3.815 · Cited by 68
Nilsson, S. C., Kalchishkova, N., Trouw, L. A., Frémeaux‐Bacchi, V., Villoutreix, B. O., & Blom, A. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200939280 · Cited by 68
Tordello, E. D., Vacca, I., Ram, S., Rappuoli, R., & Serruto, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321556111 · Cited by 68
Hollmann, T. J., Mueller‐Ortiz, S. L., Braun, M., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.037 · Cited by 67
Ricklin, D., Τζέκου, Α., Garcia, B. L., Hammel, M., McWhorter, W. J., Sfyroera, G., Wu, Y., Holers, V. M., Herbert, A. P., Barlow, P. N., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901443 · Cited by 67
Joiner, K. A., Brown, E. J., Hammer, C. H., Warren, K. A., & Frank, M. M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.845 · Cited by 66
The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes
Wagner, C., Ochmann, C., Schoels, M., Giese, T., Stegmaier, S., Richter, R., Hug, F., & Hänsch, G. M. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.04.006 · Cited by 66
Anti-C1q Autoantibodies, Novel Tests, and Clinical Consequences
Mähler, M., van Schaarenburg, R. A., & Trouw, L. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00117 · Cited by 66
Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36
Albertí, S., Marqués, G., Hernández-Allés, S., et al. (1996) · Infection and Immunity · doi:10.1128/iai.64.11.4719-4725.1996 · Cited by 66
Terrasse, R., Tacnet‐Delorme, P., Moriscot, C., Pérard, J., Schoehn, G., Vernet, T., Thielens, N. M., Guilmi, A. M. D., & Frachet, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423731 · Cited by 65
Autoantibodies against complement components and functional consequences
Dragon‐Durey, M., Blanc, C., Marinozzi, M. C., van Schaarenburg, R. A., & Trouw, L. A. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.009 · Cited by 64
The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.
Santhekadur, P. K., Rajasekaran, D., Siddiq, A., Gredler, R., Chen, D., Schaus, S. E., Hansen, U. M., Fisher, P. B., & Sarkar, D. (2012) · Europe PMC (PubMed Central) · Cited by 62
Nagro, C. J. D., Kolla, R. V., & Rickert, R. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5379 · Cited by 62
Relative Contribution of C1q and Apoptotic Cell-Surface Calreticulin to Macrophage Phagocytosis
Verneret, M., Tacnet‐Delorme, P., Osman, R., Awad, R., Grichine, A., Kleman, J.-P., & Frachet, P. (2014) · Journal of Innate Immunity · doi:10.1159/000358834 · Cited by 59
Structural Basis for Complement Evasion by Lyme Disease Pathogen Borrelia burgdorferi
Bhattacharjee, A., Oeemig, J. S., Kolodziejczyk, R., Meri, T., Kajander, T., Lehtinen, M. J., Iwaï, H., Jokiranta, T. S., & Goldman, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.459040 · Cited by 59
A re-evaluation of the role of C3 in B-cell activation
Klaus, G. G. B., & Humphrey, J. (1986) · Immunology Today · doi:10.1016/0167-5699(86)90165-9 · Cited by 57
Complement C 4 maintains peripheral B ‐cell tolerance in a myeloid cell dependent manner
Chatterjee, P., Agyemang, A. F., Alimzhanov, M. B., Degn, S. E., Tsiftsoglou, S. A., Alicot, E. M., Jones, S. A., Ma, M., & Carroll, M. C. (2013) · European Journal of Immunology · doi:10.1002/eji.201343412 · Cited by 56
Mueller‐Ortiz, S. L., Wang, D., Morales, J. E., Li, L., Chang, J., & Wetsel, R. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804207 · Cited by 56
Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide
Roumenina, L. T., Popov, K. T., Bureeva, S. V., Kojouharova, M. S., Gadjeva, M. G., Rabheru, S., Thakrar, R., Kaplun, A. P., & Kishore, U. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.04.029 · Cited by 54
Self-citationHuman complement factor H is a novel diagnostic marker for lung adenocarcinoma
Petersen, I. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1010 · Cited by 54
The role of complement in CD4+ T cell homeostasis and effector functions
Kolev, M. V., Friec, G. L., & Kemper, C. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.012 · Cited by 54
C3a(desArg) does not bind to and signal through the human C3a receptor
Wilken, H.-C., Götze, O., Werfel, T., & Zwirner, J. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00002-4 · Cited by 54
André, C., & Cota, D. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000754 · Cited by 52
C5a, But Not C3a, Increases VEGF Secretion in ARPE-19 Human Retinal Pigment Epithelial Cells
Cortright, D. N., Meade, R., Waters, S. M., Chenard, B. L., & Krause, J. E. (2009) · Current Eye Research · doi:10.1080/02713680802546658 · Cited by 52
Roumenina, L. T., Kantardjiev, A. A., Atanasov, B. P., Waters, P. J., Gadjeva, M. G., Reid, K. B. M., Mantovani, A., Kishore, U., & Kojouharova, M. S. (2005) · Biochemistry · doi:10.1021/bi051186n · Cited by 51
Self-citationStructural and functional characterization of human and murine C5a anaphylatoxins
Schatz-Jakobsen, J. A., Yatime, L., Larsen, C., Petersen, S. V., Klos, A., & Andersen, G. R. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s139900471400844x · Cited by 50
C5L2 and C5aR interaction in adipocytes and macrophages: Insights into adipoimmunology
Poursharifi, P., Lapointe, M., Pétrin, D., Devost, D., Gauvreau, D., Hébert, T. E., & Cianflone, K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.12.010 · Cited by 50
Structure of Factor H-binding Protein B (FhbB) of the Periopathogen, Treponema denticola
Miller, D. P., Bell, J. K., McDowell, J. V., Conrad, D. H., Burgner, J. W., Heroux, A., & Marconi, R. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339721 · Cited by 49
Upadhyay, A., Burman, J. D., Clark, E. A., Leung, E., Isenman, D. E., van den Elsen, J. M. H., & Bagby, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802636200 · Cited by 47
Staphylococcal Complement Inhibitor Modulates Phagocyte Responses by Dimerization of Convertases
Jongerius, I., Puister, M., Wu, J., Ruyken, M., van Strijp, J. A. G., & Rooijakkers, S. H. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902865 · Cited by 46
Ermert, D., Weckel, A., Agarwal, V., Frick, I.-M., Björck, L., & Blom, A. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.502955 · Cited by 45
Tsuruta, T., Yamamoto, T., Matsubara, S., et al. (1993) · PubMed · Cited by 44
Integrin CD11c/CD18 α-Chain Phosphorylation Is Functionally Important
Uotila, L. M., Aatonen, M., & Gahmberg, C. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.497446 · Cited by 44
Mueller‐Ortiz, S. L., Morales, J. E., & Wetsel, R. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302787 · Cited by 43
Vanhecke, D., Roumenina, L. T., Wan, H., Osthoff, M. F., Schaller, M. M., & Trendelenburg, M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34605 · Cited by 42
Self-citationWang, R., Lu, B., Gerard, C. J., & Gerard, N. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301626 · Cited by 42
Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages.
Murakami, Y., Imamichi, T., & Nagasawa, S. (1993) · PubMed Central · Cited by 42
Shao, Z., Nishimura, T., Leung, L. L. K., & Morser, J. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12956 · Cited by 41
Koleva, M., Schlaf, G., Landmann, R. M., Götze, O., Jungermann, K. A., & Schieferdecker, H. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.31883 · Cited by 40
Cutting Edge: Complement (C3d)-Linked Antigens Break B Cell Anergy
Lyubchenko, T. A., Porto, J. M. D., Holers, V. M., & Cambier, J. C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2695 · Cited by 39
Garcia, B. L., Ramyar, K. X., Ricklin, D., Lambris, J. D., & Geisbrecht, B. V. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_7 · Cited by 38
Radanova, M. A., Vasilev, V. V., Deliyska, B., Kishore, U., Ikonomov, V., & Ivanova, D. G. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.11.007 · Cited by 38
Haspel, N., Ricklin, D., Geisbrecht, B. V., Kavraki, L. E., & Lambris, J. D. (2008) · Protein Science · doi:10.1110/ps.036624.108 · Cited by 38
Structural basis for activation of the complement system by C4 cleavage
Andersen, G. R., Kidmose, R. T., Laursen, N. S., Dobó, J., Kjær, T. R., Sirotkina, S., Yatime, L., Sottrup‐Jensen, L., Thiel, S., & Gál, P. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.217 · Cited by 38
Hair, P. S., Foley, C. K., Krishna, N. K., Nyalwidhe, J. O., Geoghegan, J. A., Foster, T. J., & Cunnion, K. M. (2013) · Results in Immunology · doi:10.1016/j.rinim.2013.10.004 · Cited by 37
C5L2 is required for C5a-triggered receptor internalization and ERK signaling
Hsu, W.-C., Yang, F.-C., Lin, C.-H., Hsieh, S.-L. E., & Chen, N. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.021 · Cited by 37
Weibel–Palade bodies—sentinels of acute stress
Goligorsky, M. S., Patschan, D., & Kuo, M. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.87 · Cited by 37
Formation of transmural complement pores in serum-sensitive Escherichia coli
Bhakdi, S., Kuller, G., Muhly, M., et al. (1987) · Infection and Immunity · doi:10.1128/iai.55.1.206-210.1987 · Cited by 37
Inhibition of the Classical Pathway of Complement by Meningococcal Capsular Polysaccharides
Agarwal, S., Vasudhev, S., DeOliveira, R. B., & Ram, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303177 · Cited by 36
Lck Mediates Signal Transmission from CD59 to the TCR/CD3 Pathway in Jurkat T Cells
Lipp, A.-M., Juhász, K., Paar, C., Ogris, C., Eckerstorfer, P., Thuenauer, R., Hesse, J., Nimmervoll, B., Stockinger, H. S. J., Schütz, G. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085934 · Cited by 35
A Novel Factor I Activity in Nipah Virus Inhibits Human Complement Pathways through Cleavage of C3b
Johnson, J. B., Borisevich, V., Rockx, B., & Parks, G. D. (2014) · Journal of Virology · doi:10.1128/jvi.02427-14 · Cited by 34
Zaal, A., Lissenberg-Thunnissen, S. N., van Schijndel, G., Wouters, D., Ham, S. M. V., & ten Brinke, A. (2013) · Immunobiology · doi:10.1016/j.imbio.2012.02.014 · Cited by 33
Genetics of hemolytic uremic syndromes
Malina, M., Roumenina, L. T., Seeman, T., et al. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2011.10.028 · Cited by 33
Self-citationHundgeburth, L. C., Wunsch, M., Rovituso, D. M., Recks, M. S., Addicks, K., Lehmann, P., & Küerten, S. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.12.007 · Cited by 32
Vijayan, S., Asare, Y., Grommes, J., Soehnlein, O., Lutgens, E., Shagdarsuren, G., Togtokh, A., Jacobs, M. J. H. M., Fischer, J. W., Bernhagen, J., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.04.004 · Cited by 32
Extracellular Matrix Proteins Modulate Antimigratory and Apoptotic Effects of Doxorubicin
Said, G., Guilbert, M., Morjani, H., Garnotel, R., Jeannesson, P., & Btaouri, H. E. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/268681 · Cited by 32
Rudilla, F., Fayolle, C., Casares, N., Durántez, M., Arribillaga, L., Lozano, T., Villanueva, L., Pío, R., Sarobe, P., Leclerc, C., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.052 · Cited by 29
Factors determining penetrance in familial atypical haemolytic uraemic syndrome
Sansbury, F. H., Cordell, H. J., Bingham, C., Bromilow, G., Nicholls, A., Powell, R. J., Shields, B. M., Smyth, L., Warwicker, P., Strain, L., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102498 · Cited by 28
Jain, U., Cao, Q., Thomas, N. A., Woodruff, T. M., Schwaeble, W., Stover, C. M., & Stadnyk, A. W. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401814 · Cited by 25
Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury
Zhao, Y. H., Xu, H., Yu, W., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2176 · Cited by 22
Cited by
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
Paczosa, M. K., & Mecsas, J. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00078-15 · Cited by 1,988
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Self-citationvan der Poll, T., Shankar-Hari, M., & Wiersinga, W. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.012 · Cited by 1,010
A dynamic COVID-19 immune signature includes associations with poor prognosis
Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946
Metadata
- Authors
- Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2015-05-26
- Volume
- 6
- Pages
- 257-257
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W1499593166
- Cited by
- 1,051
- References
- 280
- FWCI
- 28.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.